EirGenix (6589) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.020x

Based on the latest financial reports, EirGenix (6589) has a cash flow conversion efficiency ratio of -0.020x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-168.94 Million ≈ $-5.32 Million USD) by net assets (NT$8.46 Billion ≈ $266.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 6589 market cap for the company's overall valuation and market capitalisation.

EirGenix - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how EirGenix's cash flow conversion efficiency has evolved over time, based on yearly financial data.

EirGenix Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EirGenix ranked by their cash flow conversion efficiency. Explore earnings quality score of EirGenix to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Energy Vault Holdings Inc NYSE:NRGV	-1.000x
Lotte Tour Dev KO:032350	-0.024x
Beijing Vastdata Technology Co Ltd SHG:603138	-0.016x
Colorlight Cloud Tech Ltd. A SHE:301391	N/A
Life & Banc Split Corp TO:LBS	-0.003x
Sinosteel Luonai Materials Technology Co. Ltd. A SHG:688119	N/A
ECN Capital Corp TO:ECN	-0.057x
Monalisa Group Co Ltd Class A SHE:002918	0.075x

Annual Cash Flow Conversion Efficiency for EirGenix (2017–2024)

The table below shows the annual cash flow conversion efficiency of EirGenix from 2017 to 2024. View 6589 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$9.26 Billion ≈ $291.69 Million	NT$-311.44 Million ≈ $-9.81 Million	-0.034x	+60.29%
2023-12-31	NT$10.02 Billion ≈ $315.61 Million	NT$-848.56 Million ≈ $-26.73 Million	-0.085x	-513.43%
2022-12-31	NT$10.68 Billion ≈ $336.57 Million	NT$-147.52 Million ≈ $-4.65 Million	-0.014x	-381.65%
2021-12-31	NT$10.43 Billion ≈ $328.56 Million	NT$-29.90 Million ≈ $-941.98K	-0.003x	+98.70%
2020-12-31	NT$1.91 Billion ≈ $60.04 Million	NT$-419.26 Million ≈ $-13.21 Million	-0.220x	+7.36%
2019-12-31	NT$3.30 Billion ≈ $104.01 Million	NT$-784.07 Million ≈ $-24.70 Million	-0.237x	-6.49%
2018-12-31	NT$2.09 Billion ≈ $65.77 Million	NT$-465.61 Million ≈ $-14.67 Million	-0.223x	-34.68%
2017-12-31	NT$1.14 Billion ≈ $36.07 Million	NT$-189.57 Million ≈ $-5.97 Million	-0.166x	--

About EirGenix

TWO:6589 Taiwan Biotechnology

Market Cap

$632.48 Million

NT$20.08 Billion TWD

Market Cap Rank

#11131 Global

#394 in Taiwan

Share Price

NT$66.40

Change (1 day)

+0.00%

52-Week Range

NT$66.40 - NT$66.40

All Time High

NT$188.50